Agilent Technologies Inc (NYSE:A)

130.03
Delayed Data
As of 4:00pm ET
 +1.39 / +1.08%
Today’s Change
78.72
Today|||52-Week Range
137.83
+9.74%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$40.8B

Company Description

Agilent Technologies, Inc. engages in the provision of application focused solutions for life sciences, diagnostics and applied chemical markets. It operates through the following segments: Life Sciences and Applied Markets, Diagnostics and Genomics and Agilent CrossLab. The Life Sciences and Applied Markets segment offers application-focused solutions that include instruments and software that enable to identify, quantify and analyze the physical and biological properties of substances and products, as well as the clinical and life sciences research areas to interrogate samples at the molecular and cellular level. The Diagnostics and Genomics segment consists of activity providing active pharmaceutical ingredients for oligo-based therapeutics as well as solutions that include reagents, instruments, software and consumables. The Agilent CrossLab segment includes startup, operational, training and compliance support, software as a service and asset management and consultative services. The company was founded in May 1999 and is headquartered in Santa Clara, CA.

Contact Information

Agilent Technologies, Inc.
5301 Stevens Creek Boulevard
Santa Clara California 95051
P:(800) 227-9770
Investor Relations:

Employees

Shareholders

Mutual fund holders50.99%
Other institutional38.56%
Individual stakeholders1.44%

Top Executives

Michael R. McMullenPresident, Chief Executive Officer & Director
Robert W. McMahonChief Financial Officer & Senior Vice President
Darlene J. S. SolomonChief Technology Officer & Senior Vice President
Katharine KnobilChief Medical Officer
Jacob ThaysenSenior Vice President